NYSE: ACRAcres Commercial Realty Corp Stock
$13.80+0.14 (+1.02%)
Updated Apr 19, 2024
ACR Price
$13.80
Fair Value Price
N/A
Market Cap
$106.93M
52 Week Low
$6.62
52 Week High
$14.35
P/E
39.43x
P/B
0.25x
P/S
0.89x
PEG
N/A
Dividend Yield
N/A
Revenue
$91.13M
Earnings
$22.39M
Gross Margin
89%
Operating Margin
24.68%
Profit Margin
3.3%
Debt to Equity
4.02
Operating Cash Flow
$46M
Beta
1.26
Next Earnings
May 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A
ACR Overview
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial real estate mortgage loans and other commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including floating and fixed rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments, commercial mortgage-backed securities, and commercial real estate equity investments. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Resource Capital Corp. and changed its name to Exantas Capital Corp. in May 2018. Exantas Capital Corp. was founded in 2005 and is based in New York, New York.
Zen Score
–
Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ACR was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ACR is good value based on its earnings relative to its share price (39.43x), compared to the US market average (40.51x)
P/E vs Market Valuation
ACR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ACR due diligence checks available for Premium users.
Be the first to know about important ACR news, forecast changes, insider trades & much more!
ACR News
Valuation
ACR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
39.43x
Industry
37.36x
Market
40.51x
ACR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ACR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ACR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.25x
Industry
0.7x
ACR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ACR's financial health
Profit margin
Revenue
$22.4M
Net Income
$6.6M
Profit Margin
7.6%
ACR's Earnings (EBIT) of $22.49M... subscribe to Premium to read more.
Interest Coverage Financials
ACR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.2B
Liabilities
$1.7B
Debt to equity
4.02
ACR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ACR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$9.4M
Investing
$54.4M
Financing
-$72.2M
ACR's operating cash flow ($45.61M)... subscribe to Premium to read more.
Debt Coverage Financials
ACR vs Mortgage REIT Stocks
Acres Commercial Realty Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.